We analyze the gathered data to create forecasting baselines, spot trends and opportunities, learn more about the characteristics and motivations of our customers, and much more. Various techniques were employed to obtain market statistics on aesthetic medicine, contingent on the nature of the material under investigation.
Market research efforts are divided into three categories: top-down for forecasting and penetration of new products, bottom-up for estimating and predicting demand size and opportunity, and combined top-down and bottom-up for complete coverage analysis.
Value-Chain-Based Sizing & Forecasting: Using competitive benchmarking, forecasting, and penetration modeling, supply-side estimations are used to understand potential revenue.
Demand-side estimations for segment modeling, heuristic forecasting, and parent and auxiliary market identification. Market share evaluation using Qualitative Functional Deployment (QFD) modeling.
We analyze the gathered data to create forecasting baselines, spot trends and opportunities, learn more about the characteristics and motivations of our customers, and much more. Various data analysis techniques are employed by us based on the kind of information we hope to find during our investigation.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Medical Aesthetics Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Medical Aesthetics Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Medical Aesthetics Market based on Product:
- Facial Aesthetic
- Body Contouring Devices
- Cosmetic Implants
- Hair Removal Devices
- Skin Aesthetic Devices
- Tattoo Removal Devices
Medical Aesthetics Market based on Technology:
- Invasive
- Non-Invasive
- Minimally Invasive
Medical Aesthetics Market based on End-user:
- Hospitals & Clinics
- Dermatology & Cosmetic Centers
Medical Aesthetics Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Cosmetic medicine is seeing an increase in minimally invasive and non-surgical aesthetic procedures, which provide a practical and less dangerous substitute for conventional surgery. These procedures, which include chemical peels, microdermabrasion, laser therapy, dermal fillers, and Botox, address a variety of aesthetic issues with outcomes that seem natural. Their simplicity in recuperation and easy resumption of everyday activities stems from their minimal downtime. Their adaptability and configurable features are making them more and more popular with people of all ages. Significantly, these therapies reduce scarring, which makes them the therapy of choice for people who are worried about surgical scars. For safe and successful results, nevertheless, only licensed medical professionals should carry out these procedures, and for individualized treatment regimens, communication with healthcare providers is essential.
In the market for medical aesthetic devices, medical aesthetics systems are strict safety regulations and compliance requirements that act as vital safety nets for patient wellbeing and treatment efficacy. Still, they pose a number of difficulties. These include obstacles to new entrants brought about by resource-intensive compliance regulations, hold-ups in product development and approvals, higher treatment costs, and stringent oversight, all of which have the potential to put non-compliant businesses in legal hot water. Furthermore, these rules restrict the freedom of practitioners and may differ globally, which increases complexity and need continuous education and training. Even while there are limitations, they ultimately put patient safety first, promote industry trust, and support long-term market viability, rewarding businesses that properly manage this regulatory environment.
The medical aesthetics market is divided into product categories, including thread lift products, physician-dispensed eyelash products, facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals and skin lighteners, tattoo removal devices, and nail treatment laser devices. By 2023, the category with the biggest market share was facial aesthetic goods. This section of the medical aesthetic devices market is expanding due to the rising demand for enhanced sensitivity and the increased usage of sophisticated technologies that enable precise diagnosis.
The medical aesthetics market is divided into two segments based on the type of procedure performed: non-surgical procedures such as lipolysis, tattoo and scar removal, hair removal, anti-aging and skin rejuvenation, and rhinoplasty, facelift, body lift, and other surgical procedures; and surgical procedures such as breast augmentation, lipolysis, and facelifts and other surgical procedures. During the projection period, the non-surgical procedures segment market by procedure’s lipolysis sector is expected to develop at the fastest rate. The segment’s quick expansion may be attributed to several factors, the most notable of which being the growing use of cutting-edge technology that allow for precision targeting of particular areas and facilitate real-time imaging in the field of medical aesthetics.
The medical aesthetics market is divided into clinics, hospitals, medical spas, beauty salons, and home care settings based on the end users. By 2022, the segment with the biggest market share was clinics, hospitals, and medical spas. The increasing use of automated systems is responsible for this segment’s largest share. Due to growing awareness, the majority of this sector can be linked to the increasing use of automated methods for early disease diagnosis in medical aesthetics clinics. The primary causes of this increase include the increasing number of aesthetic treatments performed, the digitization of patient workflows in aesthetic practices, and the increased use of modern technologies in these clinics to improve patient care.
In 2023, the US and Canada together made up North America, which held the greatest market share in the medical aesthetics industry. The medical aesthetics market is rising in North America as a result of factors like advantageous reimbursement regulations, the prominence of key industry players, and the growing applications within the healthcare sector. The older population is growing at a quick rate, and the significant number of aesthetic imaging facilities that have been established in the area is also driving the market.
- This report illustrates the most vital attributes of the Medical Aesthetics Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Medical Aesthetics Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Medical Aesthetics Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Medical Aesthetics Market.
List of Tables
TABLE 1. MEDICAL AESTHETICS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. MEDICAL AESTHETICS MARKET VALUE FOR FACIAL AESTHETIC, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. MEDICAL AESTHETICS MARKET VALUE FOR BODY CONTOURING DEVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. MEDICAL AESTHETICS MARKET VALUE FOR COSMETIC IMPLANTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. MEDICAL AESTHETICS MARKET VALUE FOR HAIR REMOVAL DEVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. MEDICAL AESTHETICS MARKET VALUE FOR SKIN AESTHETIC DEVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. MEDICAL AESTHETICS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 8. MEDICAL AESTHETICS MARKET VALUE FOR INVASIVE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. MEDICAL AESTHETICS MARKET VALUE FOR NON-INVASIVE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. MEDICAL AESTHETICS MARKET VALUE FOR MINIMALLY INVASIVE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 12. MEDICAL AESTHETICS MARKET VALUE FOR HOSPITALS & CLINICS, 2021-2030 (USD BILLION)
TABLE 13. MEDICAL AESTHETICS MARKET VALUE FOR DERMATOLOGY & COSMETIC CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA MEDICAL AESTHETICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 15. NORTH AMERICA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 18. U.S MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 19. U.S MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. U.S MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 21. CANADA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 22. CANADA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. CANADA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 24. MEXICO MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 25. MEXICO MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. MEXICO MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 27. EUROPE MEDICAL AESTHETICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 28. EUROPE MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 29. EUROPE MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. EUROPE MEDICAL AESTHETICS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION)
TABLE 31. GERMANY MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 32. GERMANY MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. GERMANY MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 34. U.K MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 35. U.K MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. U.K MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 37. FRANCE MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 38. FRANCE MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. FRANCE MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 40. ITALY MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 41. ITALY MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. ITALY MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 43. SPAIN MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 44. SPAIN MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. SPAIN MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 46. ROE MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 47. ROE MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. ROE MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC MEDICAL AESTHETICS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 50. ASIA PACIFIC MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 51. ASIA PACIFIC MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 53. CHINA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 54. CHINA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. CHINA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 56. INDIA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 57. INDIA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. INDIA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 59. JAPAN MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 60. JAPAN MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. JAPAN MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 62. REST OF APAC MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 63. REST OF APAC MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. REST OF APAC MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 65. LATIN AMERICA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 66. LATIN AMERICA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. LATIN AMERICA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 68. BRAZIL MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 69. BRAZIL MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. BRAZIL MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 71. ARGENTINA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 72. ARGENTINA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. ARGENTINA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 74. MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 75. MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 77. SAUDI ARABIA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 78. SAUDI ARABIA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. SAUDI ARABIA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 80. UAE MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 81. UAE MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. UAE MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 83. REST OF MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 84. REST OF MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 85. REST OF MIDDLE EAST AND AFRICA MEDICAL AESTHETICS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 86. ADSS: FINANCIALS
TABLE 87. ADSS: PRODUCTS & SERVICES
TABLE 88. ADSS: RECENT DEVELOPMENTS
TABLE 89. ALLERGAN AESTHETICS: FINANCIALS
TABLE 90. ALLERGAN AESTHETICS: PRODUCTS & SERVICES
TABLE 91. ALLERGAN AESTHETICS: RECENT DEVELOPMENTS
TABLE 92. BTL AESTHETICS: FINANCIALS
TABLE 93. BTL AESTHETICS: PRODUCTS & SERVICES
TABLE 94. BTL AESTHETICS: RECENT DEVELOPMENTS
TABLE 95. CANDELA MEDICAL: FINANCIALS
TABLE 96. CANDELA MEDICAL: PRODUCTS & SERVICES
TABLE 97. CANDELA MEDICAL: RECENT DEVELOPMENTS
TABLE 98. CLASSYS: FINANCIALS
TABLE 99. CLASSYS: PRODUCTS & SERVICES
TABLE 100. CLASSYS: RECENT DEVELOPMENTS
TABLE 101. CROMA PHARMA: FINANCIALS
TABLE 102. CROMA PHARMA: PRODUCTS & SERVICES
TABLE 103. CROMA PHARMA: RECENT DEVELOPMENTS
TABLE 104. CYNOSURE: FINANCIALS
TABLE 105. CYNOSURE: PRODUCTS & SERVICES
TABLE 106. CYNOSURE: DEVELOPMENTS
TABLE 107. DAEYANG MEDICAL: FINANCIALS
TABLE 108. DAEYANG MEDICAL: PRODUCTS & SERVICES
TABLE 109. DAEYANG MEDICAL: RECENT DEVELOPMENTS
TABLE 110. ESTABLISHMENT LABS: FINANCIALS
TABLE 111. ESTABLISHMENT LABS: PRODUCTS & SERVICES
TABLE 112. ESTABLISHMENT LABS: RECENT DEVELOPMENTS
TABLE 113. GALDERMA: FINANCIALS
TABLE 114. GALDERMA: PRODUCTS & SERVICES
TABLE 115. GALDERMA: RECENT DEVELOPMENTS
